The Medicines and Healthcare products Regulatory Agency (MHRA) has approved an adapted version of the Nuvaxovid COVID-19 vaccine that targets the ...

Novavax, Inc. (NASDAQ:NVAX) Q3 2024 Earnings Call Transcript ... The trial will enroll adults aged 65 years and older and is ...

People reporting long-COVID symptoms had elevated levels of cytokines, which are proteins the body makes to fight ...

The adverse event in the earlier clinical trial involved amyotrophic lateral sclerosis, which wasn't related to vaccination.

Novavax, Inc. ( NASDAQ: NVAX) Q3 2024 Earnings Conference Call November 12, 2024 8:30 AM ET ...

Novavax's COVID vaccine brought in sales of $38.21 million ... that Donald Trump as U.S. president will be a boon for ...

An emperor penguin that was found on a remote Western Australian beach on Nov. 1 is now being cared for by a registered carer ...

Santen Pharmaceutical and Arctic Vision have signed a commercial collaboration agreement for the ARVN001to treat uveitic ...

WASHINGTON (AP) — If you missed the early fall push for flu and COVID-19 vaccines, it's not too late. Health officials say it's important to get vaccinated ahead of the holidays, when respiratory bugs ...

Beyondie sulphate of potash (SoP) project. Reward Minerals announced in December 2023 that it had entered into a binding share sale agreement with the receivers and managers of Kalium Lakes to ...

Besides Sanofi deal for nuvaxovid, Novavax has few opportunities to generate additional revenue, which likely means its stock ...

Insurance Australia Group Limited (AU:IAG) has released an update. Insurance Australia Group Limited has announced a recent update on its on-market buy-back, revealing that it repurchased 421,684 ...